GILD icon

GILD - Keuangan

Overnight MarketOvernight Market

Gilead Sciences Inc

$170.39Price Up$2.33 (1.39%)
Senin, 16 November 2026 10:31 WIB
$168.06Price Up$0.11 (0.07%)
Sabtu, 14 November 2026 03:59 WIB
iconPerforma Harga
Harga kembali 1 minggu2.63%
Harga kembali 1 Bulan8.23%
Harga kembali 3 Bulan23.17%
Harga kembali 6 Bulan31.43%
Harga Tertinggi (52 Minggu)175.88
Harga Terendah (52 Minggu)116.9
Latar Belakang Perusahaan
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Income Statement

20252024202320222021

Total Revenue

29.44B28.75B27.12B27.28B27.30B

Gross Profit

23.21B22.50B27.12B21.62B20.70B

Operating Income

11.70B1.66B7.61B7.33B9.92B

Net Income

8.51B480.00M5.67B4.59B6.22B

Net Margin %

28.90%1.67%20.89%16.83%22.80%

Saham Terkait